Company
Artax Biopharma
Immunomodulation without immunosuppression
Also known as Artax Biopharma, Inc
- Business model
- B2B
- Legal name
- Artax Biopharma, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
Artax Biopharma is a clinical stage biotechnology company that develops novel treatments for autoimmune diseases.
Funding snapshot
- Total raised
- $56MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $19M2024-07-31
Funding rounds
- Round, 2024
- $19M2024-07-31, SEC form D sold, 30 investors
- Round, 2021
- $25.8M2021-12-17, SEC form D sold, 28 investors
- Round, 2021
- $2.2M2021-02-16, SEC form D sold, 19 investors
- Round, 2020
- $2M2020-04-17, SEC form D sold, 9 investors
- Round, 2019
- $750K2019-07-31, SEC form D sold, 24 investors
- Round, 2015
- $3M2015-07-29, SEC form D sold, 29 investors
- Round, 2014
- $2M2014-07-17, SEC form D sold, 18 investors
- Round, 2013
- $1.3M2013-06-24, SEC form D sold, 19 investors
Loading relationship preview